Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 229
Selected: 0
NCT IDTitle
NCT05351346Genotype-guided Treatment in DLBCL
NCT02409186A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma
NCT03637634The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
NCT05871099Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
NCT06370663First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC
NCT04552977A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
NCT04639271Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis
NCT03791125Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets
NCT04555226The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)
NCT04562337SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC
NCT04609540Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC
NCT05278546A Study of ILB2109 in Patients With Advanced Solid Malignancies
NCT07261059AI-assisted Integrated Care to Promote Colonoscopy Uptake
NCT04004975Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
NCT06686342PDO Based Drug Sensitive Test in R/M HNSCC
NCT06288360Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
NCT03489616Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients
NCT01735747Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
NCT01481818Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis
NCT01714908Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
NCT07162519Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients
NCT07187752Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes
NCT07340424A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.
NCT02848794Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
NCT06686979PDO Based Drug Sensitive Test in R/M SGC
NCT07316309CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
NCT06816771Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents
NCT03024463The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer Patients
NCT03884192Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC
NCT06312982A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
NCT01985451Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL)
NCT03414944Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases
NCT06252792Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
NCT03937414Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer Patients
NCT02284490High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
NCT03703427Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy
NCT03672136Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients
NCT03180177Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
NCT03029065Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis
NCT04963608RWS of Inetetamab HER2 Positive Advanced Breast Cancer
NCT06279104A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
NCT06844422Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
NCT05323890Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.
NCT06690216Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
NCT05054777Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort
NCT05780307IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
NCT04963595Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
NCT06716775Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.
NCT05185531A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma
NCT04047823Temperature and Injury in Radiotherapy Radiation Skin Injury